Triple challenges—small sample size in both exposure and control groups to scan rare maternal outcomes in a signal identification approach: a simulation study.
| Autor: | Thai, Thuy N, Winterstein, Almut G, Suarez, Elizabeth A, He, Jiwei, Zhao, Yueqin, Zhang, Di, Stojanovic, Danijela, Liedtka, Jane, Anderson, Abby, Hernández-Muñoz, José J, Munoz, Monica, Liu, Wei, Dashevsky, Inna, Messenger-Jones, Elizabeth, Siranosian, Elizabeth, Maro, Judith C |
|---|---|
| Předmět: |
POISSON distribution
NULL hypothesis EFFECT sizes (Statistics) PUBLIC health surveillance STATISTICAL hypothesis testing RESEARCH funding SAMPLE size (Statistics) PREGNANCY outcomes UNCERTAINTY MAXIMUM likelihood statistics DESCRIPTIVE statistics MACROLIDE antibiotics COMPARATIVE studies DATA analysis software PENICILLIN |
| Zdroj: | American Journal of Epidemiology; Dec2024, Vol. 193 Issue 12, p1805-1813, 9p |
| Abstrakt: | There is a dearth of safety data on maternal outcomes after perinatal medication exposure. Data-mining for unexpected adverse event occurrence in existing datasets is a potentially useful approach. One method, the Poisson tree-based scan statistic (TBSS), assumes that the expected outcome counts, based on incidence of outcomes in the control group, are estimated without error. This assumption may be difficult to satisfy with a small control group. Our simulation study evaluated the effect of imprecise incidence proportions from the control group on TBSS' ability to identify maternal outcomes in pregnancy research. We simulated base case analyses with "true" expected incidence proportions and compared these with imprecise incidence proportions derived from sparse control samples. We varied parameters that have an impact on type I error and statistical power (exposure group size, outcome's incidence proportion, and effect size). We found that imprecise incidence proportions generated by a small control group resulted in inaccurate alerting, inflation of type I error, and removal of very rare outcomes for TBSS analysis due to "zero" background counts. Ideally, the control size should be at least several times larger than the exposure size to limit the number of false positive alerts and retain statistical power for true alerts. This article is part of a Special Collection on Pharmacoepidemiology. [ABSTRACT FROM AUTHOR] |
| Databáze: | Complementary Index |
| Externí odkaz: |
|